Market news


UK earnings, trading statements calendar - next 7 days

...
Wednesday 1 January 
no events scheduled 
Thursday 2 January 
no events scheduled 
Friday 3 January 
no events scheduled 
Monday

Tue, 31/12/2024 - 12:54


IN BRIEF: Hot Rocks Investments gains from sales, swings to profit

Hot Rocks Investments PLC - natural resources-focused investor - Reports swing to profit in six months to the end of September. Swings to pretax profit...

Tue, 31/12/2024 - 12:45


Provexis doubles half-year revenue and looks forward to expansion

Provexis PLC on Tuesday said revenue more than doubled in the six months to September 30, reaching £785,348 compared to £387,534 in 2023.

The Reading,...

Tue, 31/12/2024 - 12:28


IN BRIEF: 88 Energy receives first partner payment, extends deadline

88 Energy Ltd - Subiaco, Australia oil exploration company focused on Alaska - Provides update on joint venture Project Phoenix with Burgundy Xploration LLC. Says...

Tue, 31/12/2024 - 12:03


IN BRIEF: Zephyr Energy receives funding for Paradox project drilling

Zephyr Energy PLC - Rocky Mountain region-focused oil and gas company that aims for responsible resource development and carbon-neutral operations - Says it has now...

Tue, 31/12/2024 - 11:41


IN BRIEF: Baker Steel appoints Fiona Perrott-Humphrey as chair

Baker Steel Resources Trust Ltd - invests in mining companies, with exposure to cement, potash, copper, gold and other materials in projects located in Australia,...

Tue, 31/12/2024 - 11:38


Walls & Futures REIT interim profit falls amid rate cut uncertainty

Walls & Futures REIT PLC on Tuesday said its performance was ‘robust’ despite uncertainty over base rate reductions slowing progress, as its pretax profit fell.

The...

Tue, 31/12/2024 - 11:12


AIM WINNERS & LOSERS: Strong 2024 for Quadrise and Rosebank

The following stocks are the leading risers and fallers on AIM on Tuesday.

----------

AIM - WINNERS

----------

ValiRx PLC, up 28% at 0.80 pence, 12-month range 0.61p-6.20p. The...

Tue, 31/12/2024 - 10:58


ValiRx extends TheoremRx exclusivity period to final May 31 deadline

ValiRx PLC on Tuesday said it has extended the exclusivity period for a proposed sub-license agreement with TheoremRx Inc for its VAL201 therapeutic candidate, setting...

Tue, 31/12/2024 - 10:58


Sareum served notice on commercial licence for cancer treatment

Sareum Holdings PLC on Tuesday said a biopharma company in the US has served notice to terminate a development & commercialisation licence for Sareum’s SRA737...

Tue, 31/12/2024 - 10:50


Pages